Follow on Google News News By Tag * Biomarker * Pharma * Medicine * Biostatistics * Oncology * Immunology * Cns * Cancer * Drug * Conference * Hospital * Training * R D * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Biomarkers Summit - Discovery, Validation and QualificationMonday 31st January & Tuesday 1st February 2011 Crown Plaza City, London, www.smi-online.co.uk/preclinical-biomarkers.asp
By: SMi Group Ltd. Monday 31st January & Tuesday 1st February 2011 Crown Plaza City, London, UK www.smi-online.co.uk/ Sponsored by: RBM Workshop: Fit for Purpose Biomarkers: From Bench to Bedside 2nd February 2010, Crowne Plaza, City hotel, London, UK www.smi-online.co.uk/ In Association with: BioScience Innovations Testimonials “Well organised with a good list of speakers from multiple areas relevant to biomarkers.” Paul Atherfold, Senior Translational Scientist, UCB-Celltech 2009 “I really enjoyed the meeting and feel like a learned a lot” Barbara Parsons, Research Microbiologist, National Centre for Toxicological Research, US Food and Drug Administration “I also enjoyed the conference very much and made lots of contacts” Miro Venturi, Senior Biomarker & Experimental Medicine Leader, Roche About It is now clear that biomarkers play an integral role in the future of medicine. With rising development costs and a declining rate of new drug discovery, pharmaceutical companies are now incorporating biomarker strategies into all new R&D processes. Promising to be the largest and most comprehensive event of its kind to date SMi’s Biomarkers Summit will feature 28 of the industry’s leading experts. Addressing key areas including: Bioinformatics, Preclinical Biomarker R&D, Translational Biomarkers and Personalised Medicine, along with dedicated Oncology, Immunology and CNS therapeutic streams. Key Speakers Huseyin Mehmet, Director of Exploratory Biomarkers, Diabetes, Merck Hans Winkler, Senior Director and Global Head, Oncology Biomarkers, Johnson & Johnson Mark Fidock, Associate Research Fellow, Head of Quantitative Biomarkers, Pfizer Karen Asin, Director, Translational Pharmacology, Takeda Andrew Payne, Senior Group Leader, Cellular Sciences, UCB Iain Kilty, Director Allergy and Respiratory Research Unit, Pfizer Ziad Taib, Statistical Science Director, Astrazeneca Ge Ruigt, Director Experimental Medicine Neuroscience, Merck Fernando Ulloa-Montoya, Head of Molecular Biology Technology Group, GlaxoSmithKline SMi Group offer excellent opportunities to profile your company through tailored sponsorship and branding packages. For details contact Alia Malick (tel: +44 (0)20 7827 6168, email: amalick@smi- Book by the 29th October and save £300 Contact Zain Philbey (tel: +44 (0) 20 7827 6722, email: zphilbey@smi- www.smi-online.co.uk/ Supported by: Bentham Science, Biomarkers in Medicine, Biotechniques, Canbiotech, Drug Discovery Today, European Life Sciences, Going to Meet, Inpharm.com, Markets & Markets, Medchem.com, Metabolomics.net, PharmaVoice, Pharmcast, PMR, Report Buyer, SelectsScience,net # # # SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information. SMi Conferences offer you an unrivalled opportunity to network within your area of business and our Workshops and Masterclasses provide an intimate, interactive forum in which to learn about the latest techniques and developments. Take advantage of SMi services and products to help you to keep up-to-date on the latest developments within your industry sector. End
Account Email Address Disclaimer Report Abuse Page Updated Last on: Dec 09, 2010
|
|